Literature DB >> 11163549

Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia.

A A Bolonna1, R W Kerwin, J Munro, M J Arranz, A J Makoff.   

Abstract

A dysfunctional glutamatergic system has been implicated in the pathophysiology of schizophrenia. The group III metabotropic glutamate receptor (mGluR) types 7 and 8 presynaptically inhibit glutamate release, thereby modulating glutamatergic transmission in the brain. We conducted association studies to investigate the novel Tyr433Phe (mGluR7) variant and the 2846-C/T (mGluR8) polymorphism in schizophrenia. Both variants, present at high frequencies, failed to demonstrate any significant association with schizophrenia (mGluR7 [Tyr433Phe] allele: P=0.33; genotype: P=0.63; mGluR8 [2846-C/T] allele: P=0.72; genotype: P=0.63).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163549     DOI: 10.1016/s0920-9964(99)00235-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  13 in total

Review 1.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

2.  Viral-mediated knockdown of mGluR7 in the nucleus accumbens mediates excessive alcohol drinking and increased ethanol-elicited conditioned place preference in rats.

Authors:  Amine Bahi
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

Review 3.  Pharmacogenetics of response to antipsychotics in patients with schizophrenia.

Authors:  Maria J Arranz; Margarita Rivera; Janet C Munro
Journal:  CNS Drugs       Date:  2011-11-01       Impact factor: 5.749

Review 4.  Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.

Authors:  John H Krystal; Sanjay J Mathew; D Cyril D'Souza; Amir Garakani; Handan Gunduz-Bruce; Dennis S Charney
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 5.  Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?

Authors:  Hans H Schiffer
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

6.  Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Authors:  Parisa Afshari; Marina Myles-Worsley; Ori S Cohen; Josepha Tiobech; Stephen V Faraone; William Byerley; Frank A Middleton
Journal:  Mol Neuropsychiatry       Date:  2015-07-08

7.  Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice.

Authors:  Suzanne A Brody; Mark A Geyer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 8.  Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.

Authors:  L Watis; S H Chen; H C Chua; S A Chong; K Sim
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

9.  The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism.

Authors:  Dexter Hadley; Zhi-Liang Wu; Charlly Kao; Akshata Kini; Alisha Mohamed-Hadley; Kelly Thomas; Lyam Vazquez; Haijun Qiu; Frank Mentch; Renata Pellegrino; Cecilia Kim; John Connolly; Joseph Glessner; Hakon Hakonarson
Journal:  Nat Commun       Date:  2014-06-13       Impact factor: 14.919

10.  Synthesis and evaluation of [11C]MMPIP as a potential radioligand for imaging of metabotropic glutamate 7 receptor in the brain.

Authors:  Tomoteru Yamasaki; Katsushi Kumata; Joji Yui; Masayuki Fujinaga; Kenji Furutsuka; Akiko Hatori; Lin Xie; Masanao Ogawa; Nobuki Nengaki; Kazunori Kawamura; Ming-Rong Zhang
Journal:  EJNMMI Res       Date:  2013-07-22       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.